Delivery Order SPE2DB20D1100-SPE2DB23FC5J6
Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,413.75 firm fixed price delivery order to Amerisourcebergen Drug Corp for Ruxience 500 MG/50 ML vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver 50 ML vials of the biosimilar drug Ruxience to its Conshohocken, Pennsylvania location by August 10, 2023 to support the Defense Logistics Agency's medical supply needs. The delivery order was issued under an existing Amerisourcebergen Corporation indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $1,703.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/10 ml vials of the pharmaceutical Ruxience. The single delivery order is for 10 vials of the drug and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 20, 2023 after an award date of September 19, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No...
- The Defense Logistics Agency Troop Support Medical awarded a $10,403.20 firm fixed price delivery order to Amerisourcebergen Drug Corp for 500 mg/50 ml vials of the drug Ruxience. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of September 26-27, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor for this requirement to supply the pharmaceutical product to the...
- The Defense Logistics Agency awarded a $5,452 delivery order to Amerisourcebergen Drug Corporation for Ruxience 500 MG/50 ML vials. Under this firm fixed price contract, Amerisourcebergen will provide 50 mL vials of the specified pharmaceutical product. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 5-6, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to...
- The Defense Logistics Agency Troop Support Medical awarded a $5,674.50 firm fixed price delivery order to Amerisourcebergen Drug Corp for 500 mg/50 ml vials of the drug Ruxience. Performance will take place in Conshohocken, Pennsylvania over one day in mid-September 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor for this order in support of the Defense Logistics Agency's medical supply chain programs. No subcontractors...
- The Defense Logistics Agency awarded a $39,673.94 delivery order to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 ml vials on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $13,014.23 to AmerisourceBergen Drug Corp for Ruxience 500 mg/50 mL vials on May 12, 2025, with a completion date of May 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. Ruxience is a biosimilar medication used in oncology and immunology treatments, reflecting the agency's ongoing need to supply critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 mL vials, valued at $13,824.28 under a firm fixed-price arrangement. This non-set-aside delivery order was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ruxience is a biosimilar monoclonal antibody used in the treatment of various cancers and...
- The Defense Logistics Agency awarded a $4,971.69 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ruxience 500 mg/50 ml vials. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 29, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $10,908.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ruxience 500 MG/50 ML vials. Under this order, Amerisourcebergen will deliver 50 mL vials of Ruxience, a biosimilar to Rituxan used to treat certain types of cancer and autoimmune disorders, to a facility in Conshohocken, Pennsylvania by August 31, 2023. As a major component of the Department of Defense that manages global logistics operations for the military services, the...